Terms: = Leukemia AND ERG, P11308, 2078
322 results:
1. An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/erg dictates erythroid vs. megakaryocytic differentiation.
Wang C; Hu M; Yu K; Liu W; Hu A; Kuang Y; Huang L; Gajendran B; Zacksenhaus E; Xiao X; Ben-David Y
Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38695236
[TBL] [Abstract] [Full Text] [Related]
2. Refining risk stratification in paediatric B-acute lymphoblastic leukaemia: Combining IKZF1
Liu HC; Huang YJ; Jaing TH; Wu KH; Chen SH; Wang SC; Yeh TC; Hsiao CC; Chang TK; Yen HJ; Huang FL; Lin PC; Hou JY; Sheen JM; Liao YM; Chang TY; Chen YC; Chiou SS; Yang CP; Pui CH; Liang DC; Shih LY
Br J Haematol; 2024 Apr; 204(4):1344-1353. PubMed ID: 38479427
[TBL] [Abstract] [Full Text] [Related]
3. erg and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia.
Behrens K; Brajanovski N; Xu Z; Viney EM; DiRago L; Hediyeh-Zadeh S; Davis MJ; Pearson RB; Sanij E; Alexander WS; Ng AP
Sci Adv; 2024 Mar; 10(10):eadj8803. PubMed ID: 38457494
[TBL] [Abstract] [Full Text] [Related]
4. Transcriptome Analysis in Mexican Adults with Acute Lymphoblastic leukemia.
Cruz-Miranda GM; Olarte-Carrillo I; Bárcenas-López DA; Martínez-Tovar A; Ramírez-Bello J; Ramos-Peñafiel CO; García-Laguna AI; Cerón-Maldonado R; May-Hau D; Jiménez-Morales S
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339034
[TBL] [Abstract] [Full Text] [Related]
5. Kikuchi disease in acute leukaemia: a distinct clinical syndrome with HLA association.
Yu SC; Lin ME
Histopathology; 2024 May; 84(6):1003-1012. PubMed ID: 38275182
[TBL] [Abstract] [Full Text] [Related]
6. A combined immune and exosome-related risk signature as prognostic biomakers in acute myeloid leukemia.
Fang Z; Fu J; Chen X
Hematology; 2024 Dec; 29(1):2300855. PubMed ID: 38186215
[TBL] [Abstract] [Full Text] [Related]
7. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
8. Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression.
Birdwell CE; Fiskus W; Kadia TM; Mill CP; Sasaki K; Daver N; DiNardo CD; Pemmaraju N; Borthakur G; Davis JA; Das K; Sharma S; Horrigan S; Ruan X; Su X; Khoury JD; Kantarjian H; Bhalla KN
Leukemia; 2024 Mar; 38(3):545-556. PubMed ID: 38086946
[TBL] [Abstract] [Full Text] [Related]
9. Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
Tsai HK; Gogakos T; Lip V; Tsai JM; Li YD; Fisch AS; Weiss J; Yang W; Grimmett L; DiToro D; Schaefer EJ; Lindsley RC; Tran TH; Caron M; Langlois S; Sinnett D; Pikman Y; Nardi V; Kim AS; Silverman LB; Harris MH
J Mol Diagn; 2023 Sep; 25(9):665-681. PubMed ID: 37419244
[TBL] [Abstract] [Full Text] [Related]
10. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
Gao Q; Ryan SL; Iacobucci I; Ghate PS; Cranston RE; Schwab C; Elsayed AH; Shi L; Pounds S; Lei S; Baviskar P; Pei D; Cheng C; Bashton M; Sinclair P; Bentley DR; Ross MT; Kingsbury Z; James T; Roberts KG; Devidas M; Fan Y; Chen W; Chang TC; Wu G; Carroll A; Heerema N; Valentine V; Valentine M; Yang W; Yang JJ; Moorman AV; Harrison CJ; Mullighan CG
Blood; 2023 Aug; 142(8):711-723. PubMed ID: 37216686
[TBL] [Abstract] [Full Text] [Related]
11. Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Witlox W; Grimm S; Howick J; Armstrong N; Ahmadu C; McDermott K; Otten T; Noake C; Wolff R; Joore M
Pharmacoeconomics; 2023 Aug; 41(8):857-867. PubMed ID: 37129774
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic value of IKZF1
Kicinski M; Arfeuille C; Grardel N; Bakkus M; Caye-Eude A; Plat G; Ferster A; Uyttebroeck A; De Moerloose B; Rohrlich P; Suciu S; Bertrand Y; Cavé H
Pediatr Blood Cancer; 2023 Jun; 70(6):e30313. PubMed ID: 36971444
[TBL] [Abstract] [Full Text] [Related]
13. RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification.
Yang Y; Shu Y; Tang Y; Zhao S; Jia Y; Ji J; Ma H; Lin T; Zheng K; Xu H; Wu Y
Cancer Med; 2023 Apr; 12(8):9156-9166. PubMed ID: 36916780
[TBL] [Abstract] [Full Text] [Related]
14. Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing.
Migita NA; Jotta PY; Nascimento NPD; Vasconcelos VS; Centoducatte GL; Massirer KB; Azevedo AC; Brandalise SR; Yunes JA
Blood Adv; 2023 Jul; 7(13):2957-2971. PubMed ID: 36848637
[TBL] [Abstract] [Full Text] [Related]
15. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB
Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545
[TBL] [Abstract] [Full Text] [Related]
16. Novel high-risk acute myeloid leukemia subgroup with erg amplification and Biallelic loss of TP53.
Schandl CA; Mazzoni S; Znoyko I; Nahhas GJ; Chung D; Ding Y; Hess B; Wolff DJ
Cancer Genet; 2023 Apr; 272-273():23-28. PubMed ID: 36657266
[TBL] [Abstract] [Full Text] [Related]
17. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial.
Schwab C; Cranston RE; Ryan SL; Butler E; Winterman E; Hawking Z; Bashton M; Enshaei A; Russell LJ; Kingsbury Z; Peden JF; Barretta E; Murray J; Gibson J; Hinchliffe AC; Bain R; Vora A; Bentley DR; Ross MT; Moorman AV; Harrison CJ
Leukemia; 2023 Mar; 37(3):529-538. PubMed ID: 36550215
[TBL] [Abstract] [Full Text] [Related]
18. ETS Fight Club on Microsatellite Enhancers.
Mercher T
Blood Cancer Discov; 2023 Jan; 4(1):2-4. PubMed ID: 36538046
[TBL] [Abstract] [Full Text] [Related]
19. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
[TBL] [Abstract] [Full Text] [Related]
20. UBTF-internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia.
Kaburagi T; Shiba N; Yamato G; Yoshida K; Tabuchi K; Ohki K; Ishikita E; Hara Y; Shiraishi Y; Kawasaki H; Sotomatsu M; Takizawa T; Taki T; Kiyokawa N; Tomizawa D; Horibe K; Miyano S; Taga T; Adachi S; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2023 Apr; 62(4):202-209. PubMed ID: 36448876
[TBL] [Abstract] [Full Text] [Related]
[Next]